Turning Data into Decisions: What National Medicine Quantification Actually Requires
Good quantification isn't just a spreadsheet exercise. It's what stands between a country's HIV and TB programs and a stockout. Here's what the process actually demands.
Quantification & Supply Planning3 min read
Rosalie Faniyo
Quantifying national demand for medicines like antiretrovirals and TB treatments sounds like a technical, back-office task. In practice, it's one of the highest-stakes exercises a health program runs. Get it wrong, and patients face stockouts, or expired surplus sits unused while budgets run dry elsewhere.
Reliable quantification depends on triangulating multiple imperfect data sources: consumption data from facilities that don't always report on time, morbidity and patient-load estimates, and procurement lead times that vary program to program. No single source is sufficient on its own, and over-relying on any one of them is usually where forecasts go wrong.
It also depends on process, not just data. Building consensus among national program managers, procurement units, and technical partners before numbers are finalized matters as much as the calculation itself, because the people who will act on the forecast need to trust it.
Having supported quantification and supply-chain country-profile work across dozens of countries, I've learned that the strongest programs treat this as a standing discipline, reviewed on a regular cadence, not a one-off exercise ahead of a funding cycle. That consistency is what ultimately keeps medicines on the shelf.
- Quantification
- Global Health